Literature DB >> 10758580

Thalidomide in Oncology: The Peril and the Promise.

.   

Abstract

Entities:  

Year:  1999        PMID： 10758580

Source DB:  PubMed          Journal:  Cancer Control        ISSN： 1073-2748            Impact factor:   3.302


× No keyword cloud information.
  4 in total

1.  Phase II study of thalidomide in the treatment of recurrent glioblastoma multiforme.

Authors:  G M Marx; N Pavlakis; S McCowatt; F M Boyle; J A Levi; D R Bell; R Cook; M Biggs; N Little; H R Wheeler
Journal:  J Neurooncol       Date:  2001-08       Impact factor: 4.130

2.  Targeted therapy in melanoma.

Authors:  Hussein Tawbi; Neelima Nimmagadda
Journal:  Biologics       Date:  2009-12-29

3.  Thalidomide in dermatology: revisited.

Authors:  Iffat Hassan; Konchok Dorjay; Parvaiz Anwar
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

4.  Thalidomide and discoid lupus erythematosus: case series and review of literature.

Authors:  Giovanna Malara; Chiara Verduci; Maria Altomonte; Maria Cuzzola; Caterina Trifirò; Cristina Politi; Giovanni Tripepi
Journal:  Drugs Context       Date:  2022-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.